Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin

Background and Objectives: Aspirin (acetylsalicylic acid—ASA) is a first-line antiplatelet therapy provided to patients with coronary artery disease (CAD). However, it has been demonstrated that 20–30% of these patients are non-sensitive to their ASA therapy. ASA non-sensitivity is a phenomenon wher...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Hamzah, Gallant, Reid, Jain, Shubha, Al-Omran, Mohammed, De Mestral, Charles, Greco, Elisa, Wheatcroft, Mark, Alazonni, Ashraf, Abdin, Rawand, Rand, Margaret L., Ni, Heyu, Qadura, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600331/
https://www.ncbi.nlm.nih.gov/pubmed/33023261
http://dx.doi.org/10.3390/medicina56100519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600331/
https://www.ncbi.nlm.nih.gov/pubmed/33023261
http://dx.doi.org/10.3390/medicina56100519

Ejemplares similares